Mounjaro 5mg weight loss: what actually happens at this stage

The myth that 5mg is an 'in-between' dose going nowhere

A lot of people arrive at 5mg thinking they are simply passing through on the way to something stronger. That framing undersells what this dose actually does. The 2.5mg pen, the one used for the first four weeks, exists primarily as a tolerability step, letting your digestive system adapt to tirzepatide before the medicine starts doing its real job. Once you move to 5mg, the dual GIP and GLP-1 receptor activation reaches a level where appetite suppression becomes genuinely noticeable for most people: meals feel smaller, the urge to snack fades, and energy intake typically drops without conscious effort.

This does not mean 5mg is the destination. But treating it as a throwaway step misses the point. Some people stay at 5mg longer than the standard four-week window if their prescriber judges it right for them, perhaps because they are losing weight well, or because GI side effects need more time to settle. The decision about when to titrate upward belongs to the prescriber, not the calendar. Worth knowing before you assume you should be on a higher dose already.

The NHS medicines page for tirzepatide confirms that treatment starts at 2.5mg to minimise side effects, with dose increases guided by clinical response, a useful reference if you want the patient-level detail straight from the source.

How much weight loss does 5mg Mounjaro actually produce?

The honest answer is that clinical trials were not designed to isolate a single dose step's contribution to weight loss, they reported outcomes across the full 72-week programme at each maintenance dose. SURMOUNT-1, published in the New England Journal of Medicine, showed average body-weight reductions of around 15%, 19.5%, and 20–21% at the 5mg, 10mg and 15mg maintenance doses respectively over 72 weeks in adults without diabetes. These are maintenance-dose results, not what happens in the first four to eight weeks.

In practice, weight loss on 5mg Mounjaro tends to be modest in the early weeks and then builds. People who reach 5mg after starting at 2.5mg are often only a few weeks into treatment, and the cumulative effect grows with time at a given dose. Realistic expectations matter here: asking how much you will lose at 5mg specifically is a bit like asking how fast a car goes in second gear, the answer depends heavily on how long you stay there and everything else going on. Higher doses tend to produce greater average loss, but 5mg still moves the dial meaningfully for many people.

If you are not seeing any response after several weeks at 5mg, the question of whether to titrate or investigate is one to raise directly with your prescriber rather than drawing conclusions alone.

Side effects and practical experience at 5mg

The most commonly reported side effects at any Mounjaro dose are gastrointestinal: nausea, loose stools, constipation, indigestion, and burping are the usual complaints. They tend to peak in the first week or two after a dose increase, then settle for most people. Moving from 2.5mg to 5mg is a meaningful step up, so some people find their symptoms return briefly, not a sign that the medicine is not working, just the body recalibrating.

Eating smaller, lower-fat meals, staying well hydrated, and avoiding lying down straight after eating all help. Specific dosing guidance and a full side-effect list are in the Patient Information Leaflet supplied with your pen; the prescriber reviewing your case is the right person to contact if symptoms are severe or persistent. Urgent medical attention is needed for severe stomach pain that radiates to the back, a potential sign of pancreatitis, flagged in a January 2026 MHRA Drug Safety Update on GLP-1 medicines, and something to take seriously rather than wait out.

Storage is straightforward: keep the pen in the fridge between 2°C and 8°C, but the exact room-temperature window you have if the fridge is not available is stated in the leaflet, follow that rather than any figure you find online. For broader context on the treatment and how each dose fits the bigger picture, the Mounjaro overview covers everything in one place.

Who receives a 5mg prescription and what happens next

Mounjaro is licensed for adults with a BMI of 30 or above, or 27 and above with at least one weight-related condition, including type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnoea. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. Eligibility is assessed at consultation; BMI alone does not guarantee a prescription, and the prescriber considers the full clinical picture.

The standard approach is to begin at 2.5mg, then move to 5mg after four weeks, and continue titrating roughly every four weeks based on response and tolerability, up to a maximum of 15mg. A prescriber at a GPhC-registered pharmacy like ours reviews each step before a dose increase is issued, no increase goes out without that clinical check. If you are weighing up the cost of private treatment across the dose schedule, the context around Eli Lilly's 2025 UK price changes is worth reading before making decisions.

Our clinical team reviews every consultation personally, a real prescriber, not an automated system, reads your answers the same day. If you want to understand whether Mounjaro is suitable for your situation, speaking to our prescribers is the place to start.